The promoter of miR-765 binds directly to HOXB9, promotes self-transcription and then targets FOXA2 to regulate FOXA2, resulting in a decrease in FOXA2 and an increase in melanoma tumor stem cells. Here, HOXB9 is linked to neoplasm.